4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001209191-20-009871
Options or other derivatives
- Chief Financial Officer acquired 85,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Cohen Chad M Chief Financial Officer | 2020-02-13 | Grant or award · Stock Option (Right to Buy) | +85,000 | 85,000 | D | ||
Loading xslF345X03/doc4.xml…